<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B231B376-3648-43BE-8BFD-678BEA18BFF3"><gtr:id>B231B376-3648-43BE-8BFD-678BEA18BFF3</gtr:id><gtr:name>Phillips Healthcare</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B231B376-3648-43BE-8BFD-678BEA18BFF3"><gtr:id>B231B376-3648-43BE-8BFD-678BEA18BFF3</gtr:id><gtr:name>Phillips Healthcare</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7D72B01B-ACC6-441F-B961-118B634A4F27"><gtr:id>7D72B01B-ACC6-441F-B961-118B634A4F27</gtr:id><gtr:firstName>Victoria</gtr:firstName><gtr:surname>Chapman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15074"><gtr:id>8DADDF03-3AB7-4D22-9901-424EB43AF3AC</gtr:id><gtr:title>23Na MRI: New frontiers in clinical imaging and diagnostics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15074</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>This proposal aims to apply recent technical developments in MRI to exploit the ?untapped potential? of sodium (23Na) MRI to drive the translation of 23Na imaging from bespoke research to a clinical research tool. We propose to build on the MRC-led investment in MRI through the Clinical Research Capabilities &amp;amp; Technologies Initiative (CRCTI) award to the Sir Peter Mansfield Imaging Centre (SPMIC) at the University of Nottingham to establish a platform centre for high and ultra-high field 23Na clinical imaging to meet the following objectives:
1) Produce a set of optimised novel protocols for 23Na imaging that can be used at high and ultra-high magnetic field (3 and 7 Tesla) strengths in vivo. In addition, we will develop novel 23Na MR rheometry methods to study blood biomechanics in health and disease.
2) Apply these measures to study kidney disease as an exemplar clinical application to facilitate development of a wider range of 23Na imaging applications, including brain, lung, gut and musculoskeletal system.
3) Develop measures of tissue sodium content (TSC) and the cortico-medullary sodium gradient, sodium velocity and multiple quantum filtered (MQF) methods as markers of tubule and nephron function, tissue damage or fibrosis, and regional variation in glomerular filtration.
4) Apply TSC and MQF measures in skin/muscle, where tissue sodium accumulation may be a biomarker for a hypertensive kidney.
5) Develop novel data analysis methods for 23Na imaging for biomarker discovery and validation analytics.
To ensure sustainability of 23Na imaging expertise in the UK, a cohort of postgraduate students, postdoctoral researchers, clinical research fellows, and associated clinical and non-clinical academic staff will receive training and acquire knowhow in this area. A focused workshop will also be organised to ensure effective knowledge transfer of the proposed innovations to wider academic and commercial research communities.</gtr:technicalSummary><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>672000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Phillips Healthcare</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Philips</gtr:description><gtr:id>A2276F07-80B1-4540-A73D-9B19336DF490</gtr:id><gtr:impact>Collaboration is with industry</gtr:impact><gtr:outcomeId>58c7091c6d03c8.05828724-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on development of sodium imaging</gtr:partnerContribution><gtr:piContribution>Development of coils for sodium imaging. Implementation of multiple channel sodium imaging.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>KRUK visit</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>01F18DCF-30C8-4746-A43A-029C1176E1C8</gtr:id><gtr:impact>Visit of kidney research UK, promoted work on sodium imaging.</gtr:impact><gtr:outcomeId>58c706746f7da0.55944050</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Chapter ISMRM invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F6AF5AFC-94AF-4876-8D72-58864A38C785</gtr:id><gtr:impact>Invited talk at the British Chapter ISMRM conference on body imaging in which proton and sodium imaging was described.</gtr:impact><gtr:outcomeId>58c7800a9590f6.36165892</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>87784</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>F0159B51-1EF9-4957-A9D5-C1600E28F6E7</gtr:id><gtr:outcomeId>58c70fc397cf73.63974646</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Development of sodium surface coil for skin imaging, and proton coil for imaging skin thickness.</gtr:description><gtr:id>F41D7186-153D-4328-AC90-A8365D36A1B5</gtr:id><gtr:impact>Sodium skin coil measures</gtr:impact><gtr:outcomeId>58c705b7876d88.86720898</gtr:outcomeId><gtr:title>Development of sodium surface coil for skin measures, and proton coil</gtr:title><gtr:type>Systems, Materials &amp; Instrumental Engineering</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>10A866FD-EFE7-4D9C-BD69-E4BE1A7184BC</gtr:id><gtr:title>Sodium MRI: a new frontier in imaging in nephrology.</gtr:title><gtr:parentPublicationTitle>Current opinion in nephrology and hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a49fda75c5ac4d6bde7f919d83c67eac"><gtr:id>a49fda75c5ac4d6bde7f919d83c67eac</gtr:id><gtr:otherNames>Francis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1062-4821</gtr:issn><gtr:outcomeId>5aa198fd274fe7.88601094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72858C9B-E2F0-498E-9DE9-137A3CE6E464</gtr:id><gtr:title>Imaging the kidney using magnetic resonance techniques: structure to function.</gtr:title><gtr:parentPublicationTitle>Current opinion in nephrology and hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe934b3cba07b0eada5c23a624fa5dff"><gtr:id>fe934b3cba07b0eada5c23a624fa5dff</gtr:id><gtr:otherNames>Mahmoud H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1062-4821</gtr:issn><gtr:outcomeId>58c70ac8df3661.11313731</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15074</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>